|
FY2016
12 months to Dec 31, 2016
|
FY2015
12 months to Dec 31, 2015
|
FY2014
12 months to Dec 31, 2014
|
FY2013
12 months to Dec 31, 2013
|
FY2012
12 months to Dec 31, 2012
|
|
|---|---|---|---|---|---|
| Net income | |||||
| Cash flows from operating activities: | |||||
| Net income | |||||
| Loss from discontinued operations, net of income taxes | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization expense | |||||
| Deferred income tax expense | |||||
| Stock-based compensation | |||||
| Tax benefit from exercise of stock options | |||||
| Amortization of debt issuance costs | |||||
| Loss on disposition of assets | |||||
| Unrealized loss (gain) on derivative instrument | |||||
| Loss from equity method investee | |||||
| Changes in operating assets and liabilities, net of effects of acquisitions: | |||||
| Increase in receivables | |||||
| Decrease (increase) in inventories and work-in-process on medical interiors and products contracts | |||||
| Decrease (increase) in prepaid expenses and other current assets | |||||
| Decrease (increase) in costs in excess of billings | |||||
| Increase (decrease) in accounts payable, other accrued liabilities, and other liabilities | |||||
| Increase (decrease) in deferred revenue and billings in excess of costs | |||||
| Net cash provided by continuing operating activities | |||||
| Net cash used by discontinued operating activities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Acquisition of subsidiaries (note 2) | |||||
| Acquisition of subsidiaries | |||||
| Buy-out of previously leased aircraft | |||||
| Acquisition of property and equipment | |||||
| Acquisition of hospital programs | |||||
| Proceeds from disposition and sale of equipment and assets held for sale | |||||
| Decrease (increase) in other assets, net | |||||
| Net cash used by continuing investing activities | |||||
| Net cash provided by discontinued investing activities | |||||
| Net cash used by investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from issuance of common stock | |||||
| Tax benefit from exercise of stock options | |||||
| Payments for purchases of common stock | |||||
| Borrowings under line of credit | |||||
| Payments under line of credit | |||||
| Proceeds from long-term debt | |||||
| Payments for financing costs | |||||
| Payments of long-term debt | |||||
| Payments of capital lease obligations | |||||
| Proceeds from redeemable non-controlling interests | |||||
| Net cash provided (used) by continuing financing activities | |||||
| Net cash provided (used) by financing activities | |||||
| Increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of year | |||||
| Cash and cash equivalents at end of year | |||||
| Interest paid in cash during the year | |||||
| Income taxes paid in cash during the year | |||||
Loading...